Article Text

PDF
Inflammatory bowel disease
  1. R M Beattie1,
  2. N M Croft2,
  3. J M Fell3,
  4. N A Afzal1,
  5. R B Heuschkel4
  1. 1Paediatric Medical Unit, Southampton General Hospital, Southampton, UK
  2. 2Centre for Adult and Paediatric Gastroenterology, Institute of Cell and Molecular Science, Barts and The London, Queen Mary’s School of Medicine and Dentistry, London, UK
  3. 3Department of Paediatric Gastroenterology, Chelsea and Westminster Hospital, London, UK
  4. 4Centre for Paediatric Gastroenterology, Royal Free Hospital, London, UK
  1. Correspondence to:
    Dr R M Beattie
    Paediatric Medical Unit, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK; mark.beattie{at}suht.swest.nhs.uk

Abstract

Twenty five per cent of inflammatory bowel disease presents in childhood. Growth and nutrition are key issues in the management with the aim of treatment being to induce and then maintain disease remission with minimal side effects. Only 25% of Crohn’s disease presents with the classic triad of abdominal pain, weight loss, and diarrhoea. Most children with ulcerative colitis have blood in the stool at presentation. Inflammatory markers are usually although not invariably raised at presentation (particularly in Crohn’s disease). Full investigation includes upper gastrointestinal endoscopy and ileocolonoscopy. Treatment requires multidisciplinary input as part of a clinical network led by a paediatrician with special expertise in the management of the condition.

  • CD, Crohn’s disease
  • IBD, inflammatory bowel disease
  • UC, ulcerative colitis
  • inflammatory bowel disease
  • Crohn’s disease
  • ulcerative colitis

Statistics from Altmetric.com

Footnotes

  • Competing interests: none declared

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.